Weekly rapamycin may blunt muscle gains in older adults despite exercise

Key Takeaways

• •Problem: As people age, their muscles don’t respond as well to exercise due to overactive mTOR, which blocks cellular cleanup (autophagy).
• •Core methods: Weekly rapamycin (6 mg), home-based exercise (three times per week), and a 12-week study duration.
• •How methods work: Rapamycin blocks mTOR to allow autophagy (cellular cleanup), and exercise is meant to rebuild muscle after; the idea was to separate these in time to get both benefits.
• •Expected outcomes: The rapamycin group improved less in muscle function than the placebo group, suggesting rapamycin interfered with exercise benefits.
• •Implementation timeframe: Effects were measured over 12 weeks, with rapamycin taken once weekly after exercise sessions.

Overview

Age-related muscle decline (sarcopenia) is linked to mTORC1 overactivation and impaired autophagy. The 'cycling hypothesis' proposes that intermittent rapamycin use could enhance muscle function by periodically inhibiting mTORC1 to promote autophagy, followed by exercise to stimulate rebuilding. This study tested this hypothesis in a 12-week, double-blind, placebo-controlled trial in 40 older adults using weekly 6 mg rapamycin and a thrice-weekly home exercise program. The goal was to determine if rapamycin could amplify exercise benefits, but results instead indicated functional blunting.

Key Terms

How to Apply

1. 1.Step 1: Enroll adults aged 65–85 who are not currently on a regular exercise program and randomize them to receive either 6 mg rapamycin or placebo once weekly.
2. 2.Step 2: Deliver exercise bikes to participants’ homes and instruct them to perform moderate-intensity cycling for 30–45 minutes on days 1, 3, and 5 of each week.
3. 3.Step 3: Administer rapamycin or placebo on day 6 of each week for 12 weeks, ensuring double-blinding and using enteric-coated capsules (e.g., Rapamune) to ensure consistent absorption.
4. 4.Step 4: Measure muscle function using the 30-second chair stand test, 6-minute walk test, and hand grip strength at baseline and week 12.
5. 5.Step 5: Collect blood samples to assess safety markers including CRP, HbA1c, and adverse events, with special attention to infections and metabolic changes.

Participants will show improvements in muscle function due to exercise, but those taking weekly rapamycin at 6 mg are likely to show smaller gains compared to placebo, particularly in chair stand performance, due to mTORC1 inhibition interfering with exercise-induced muscle adaptation.

Studies from Description (1)